Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial ribosomal protein S31 (MRPS31) is a structural protein component of the small (28S) subunit of the mitochondrial ribosome (mitoribosome). It is encoded by a nuclear gene and imported into mitochondria to participate in mitochondrial protein synthesis. MRPS31 contributes to the ribosomal structure, facilitating translation of mitochondrial mRNAs vital for mitochondrial function and energy production. Unlike prokaryotic ribosomes, mammalian mitochondrial ribosomes do not contain 5S rRNA, and have a higher protein-to-rRNA ratio. MRPS31 does not serve as a receptor, enzyme, transporter, or direct drug target. There is no established direct disease linkage, although one study associated variants in this gene with Type 1 diabetes, but its causative or functional relevance is not clarified. No drugs, biomarkers, or toxicity data are directly associated with MRPS31.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial ribosomal protein S31 (MRPS31).